SEC FIlings

16 May

SEC FIlings

Quarterly report for quarter ending Mar 31, 2022

November 17, 2022
Posted by Jitendra

16 May

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

13 May

SEC FIlings

Registration of securities, business combinations

November 17, 2022
Posted by Jitendra

11 May

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

29 Apr

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

26 Apr

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

25 Apr

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

13 Apr

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

11 Apr

SEC FIlings

Current report – Amendment

November 17, 2022
Posted by Jitendra

11 Apr

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

Quarterly report for quarter ending Mar 31, 2022

Prospectuses and communications, business combinations

Registration of securities, business combinations

Prospectuses and communications, business combinations

Prospectuses and communications, business combinations

Prospectuses and communications, business combinations

Prospectuses and communications, business combinations

Prospectuses and communications, business combinations

Current report – Amendment

Current report

Gloperba Launch – Nasdaq-2024

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch